Scholars Central

Mini reviewPublished 18 Sep 2023

Why is pacemaker-induced cardiomyopathy so fascinating?

Authors: Christoph Melzer

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Today Cardiac Resynchronization Therapy (CRT) upgrade is the therapy of choice for Pacemaker-Induced Cardiomyopathy (PICM). Melzer et al., recently published the largest prospective study revealing the effectiveness of a CRT upgrade in patients suffering from PICM in an outpatient clinic. 55 patients received a CRT upgrade. 43.6% of patients were > 80 years (83.4 + 2.9 years). For the primary endpoint, Left Ventricular End Systolic Volume (LVESV) decreased from 101.6 + 48.2 ml to 75.9 + 35.8 ml (p 80 years) benefit from upgrading CRT to the same extent as younger patients. In conclusion there are no reasonable arguments against the CRT upgrade in patients with PICM

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Interventional Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Christoph Melzer”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels